One of Australia’s leading biotech entrepreneurs

Paul Hopper is one of Australia’s leading entrepreneurs in biotech. He has just been involved in selling Viralytics for $500 million to Merck and Company so Alan Kohler gave him a call to find out how it all came about.

Become a TCI Community Member Now

Stay up to date and make better informed decisions.
Get access to all this exclusive content and so much more every week!

  • $1 for the first month
  • $25/month membership
  • Cancel anytime, no lock in contract
  • Access to Private Facebook group
  • Smartphone App (coming soon)